Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,286 papers from all fields of science
Search
Sign In
Create Free Account
Benign Ovarian Sex Cord-Stromal Tumor
Known as:
OVARIAN SEX CORD-STROMAL TUMOR, BENIGN
, Benign Sex Cord-Stromal Tumor of the Ovary
, Benign Sex Cord-Stromal Tumor of Ovary
Expand
A sex cord-stromal tumor arising from the ovary, without metastatic potential.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
9 relations
Adenocarcinoma Cell with Intracytoplasmic Mucin
CDISC SEND Tumor Findings Results Terminology
Clinical Data Interchange Standards Consortium Terminology
Female Reproductive System
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2014
Review
2014
Outcomes among patients with sex cord stromal tumour of ovary: experience from Pakistan.
Sohail Sarwar
,
N. Siddiqui
,
S. Ather
,
A. Hannan
,
A. Ali Syed
,
W. Zafar
Journal of Ayub Medical College
2014
Corpus ID: 3080074
BACKGROUND Ovarian sex cord-stromal tumours (SCST) are relatively uncommon neoplasms that account for approximately 5-7% of all…
Expand
2009
2009
Sclerosing Stromal Tumor: An Important Differential Diagnosis of Ovarian Neoplasms in Childhood and Adolescence
K. Gwin
,
A. Mariño-Enríquez
,
M. Martel
,
M. Reyes-Múgica
Pediatric and Developmental Pathology
2009
Corpus ID: 30329035
Sclerosing stromal tumors are an uncommon type of benign ovarian sex cord-stromal tumor. Histologically, they are characterized…
Expand
1993
1993
Ectopic ACTH syndrome due to bilateral ovarian androblastoma with double, gynandroblastic differentiation in one ovary.
A. A. Kasperlik-Załuska
,
Ludwika Sikorowa
,
+4 authors
Maciej Wysocki
European Journal of Obstetrics, Gynecology, and…
1993
Corpus ID: 61803
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE